Energy ray curable composition for three-dimensional modeling

The described composition addresses the lack of stress retention and toughness in existing 3D modeling materials by incorporating a high glass transition temperature polymer compound, forming a phase-separated structure that enhances durability and flexibility, suitable for dental and orthodontic applications.

JP7581045B2Active Publication Date: 2024-11-12KURARAY NORITAKE DENTAL
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2020219728
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-12-28
Publication Date
2024-11-12
Estimated Expiration
2040-12-28

AI Technical Summary

Technical Problem

Existing energy beam-curable three-dimensional modeling compositions lack sufficient stress retention and toughness, particularly for applications involving flexible materials and oral devices that require both flexibility and durability.

Method used

A composition comprising a polymerizable monomer, a photopolymerization initiator, and a polymer compound with a glass transition temperature of 140°C or higher, which forms a phase-separated structure with a highly continuous non-polymerizable phase, enhancing stress retention and toughness.

Benefits of technology

The composition achieves excellent stress retention and toughness, making it suitable for dental and orthodontic applications such as mouthpieces and mouthguards, while maintaining flexibility and preventing breakage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581045000001
    Figure 0007581045000001
  • Figure 0007581045000002
    Figure 0007581045000002
  • Figure 0007581045000003
    Figure 0007581045000003
Patent Text Reader

Abstract

To provide energy beam curable compositions for stereo-lithography that have curability to enable modeling by stereo-lithography and excellent stress retention and toughness of moldings formed by stereo-lithography.SOLUTION: A composition for energy beam curable stereo-lithography comprises a polymerizable monomer (a), a photoinitiator (b), and a polymer compound (c) which has no polymerizable groups and a glass transition temperature of 140°C or higher.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to an energy ray-curable composition for three-dimensional modeling, a three-dimensional object using the same, and a method for producing the same. [Background technology]

[0002] Optical 3D modeling technology, which creates objects by curing photocurable resin based on 3D CAD data using laser scanning or projecting beams using a projector system and stacking the resulting cured layers, has been attracting attention. Optical 3D modeling technology (hereinafter, "optical 3D modeling" will also be referred to as "3D modeling") allows prototypes to be created easily and quickly without the need for metal molds or casting molds, reducing the time and cost required from product development design to production. With the rapid spread of 3D CAD, 3D modeling technology has been adopted in a wide range of industrial fields, including automobile parts, electrical equipment, and medical equipment.

[0003] As the three-dimensional modeling technology improves and the fields of application expand, attempts are being made to apply this technology not only to prototypes but also to final products, and the performance required of the energy beam curable three-dimensional modeling composition is also increasing. Cutting processing technology cannot perform fine processing on flexible materials or process final products with shapes that are difficult to penetrate with a drill, such as hollow shapes. Therefore, there is a demand for energy beam curable resins that are flexible materials and can form shaped objects with excellent modeling accuracy when cured.

[0004] Furthermore, among dental materials, oral devices that may come into contact with soft tissues such as mucous membranes and tongues, such as orthodontic mouthpieces such as aligners and retainers used in orthodontic treatment, mouthpieces for treating sleep disorders and temporomandibular joint disorders, and occlusal splints and mouthguards, are commonly required to have stress retention and resistance to breakage (high toughness) in addition to flexibility. If the stress retention is impaired, the oral device will gradually lose stress when deformed by the force applied from the teeth and temporomandibular joint, and the effects of treatment such as movement and retention of teeth and temporomandibular joints will not be obtained. If the flexibility is impaired, the device will be uncomfortable to wear, and if it becomes easily broken, it will need to be frequently remade, and there will be problems such as a risk of aspiration and oral injury. However, the present inventors have studied and found that in order to improve the stress retention of a molded object molded by polymerization and curing with strong energy rays used in optical three-dimensional modeling, it is necessary to use a three-dimensional modeling composition with a high crosslink density and glass transition temperature for the molded object, but when such a composition is used, the toughness of the molded object will be easily impaired.

[0005] Patent Document 1 discloses a composition for optical three-dimensional modeling that contains a water-soluble monomer and a polymerization initiator that can be used in cationic polymerization, a water-soluble monomer, a polymerization initiator, and a sensitizer that can be used in radical polymerization, and a diallyl phthalate-based polymer. It is described that this composition can shorten the curing time, and can produce a three-dimensional object that has excellent strength, is small in deformation, and is highly safe for the human body and the environment.

[0006] Patent Document 2 discloses a printable composition containing a polymerizable component having a viscosity of at least 20,000 cP at 25° C., a solvent, a photopolymerization initiator, and a polymerization inhibitor. It is described that this composition has a low viscosity, an appropriate curing rate, and the cured product has excellent water resistance. [Prior art documents] [Patent documents]

[0007] [Patent Document 1] Patent Publication No. 2018-100340 [Patent Document 2] Patent Publication No. 2019-519405 Summary of the Invention [Problem to be solved by the invention]

[0008] However, Patent Documents 1 and 2 are silent about achieving both stress retention and toughness.

[0009] In view of the above circumstances, the problem that the present invention aims to solve is to provide an energy ray-curable composition for three-dimensional modeling, which has curability that enables modeling by three-dimensional modeling, and which has excellent stress retention and toughness of objects formed by three-dimensional modeling. [Means for solving the problem]

[0010] Means for Solving the Problems The inventors conducted intensive research to solve the above problems, and as a result, discovered that an energy ray-curable composition for three-dimensional modeling containing a specific polymer compound can solve the above problems. Based on this finding, the inventors conducted further research and completed the present invention.

[0011] That is, the present invention includes the following inventions. [1] An energy ray-curable composition for three-dimensional modeling, comprising a polymerizable monomer (a), a photopolymerization initiator (b), and a polymer compound (c), the polymer compound (c) having no polymerizable group and having a glass transition temperature of 140°C or higher. [2] The energy ray-curable composition for three-dimensional object formation according to [1], wherein the photopolymerization initiator (b) is a radical photopolymerization initiator (b1). [3] The energy ray-curable composition for three-dimensional modeling according to [1] or [2], wherein the polymerizable monomer (a) is a polymerizable monomer not having an alicyclic skeleton. [4] The energy ray-curable composition for three-dimensional object formation according to any one of [1] to [3], wherein the polymerizable monomer (a) has a glass transition temperature of 40° C. or lower. [5] The energy ray-curable composition for three-dimensional modeling according to any one of [1] to [4], wherein the polymer compound (c) has a glass transition temperature of 160° C. or higher. [6] The energy ray-curable composition for three-dimensional modeling according to any one of [1] to [5], wherein the polymer compound (c) is at least one selected from the group consisting of polycarbonate, polysulfone, polyethersulfone, and polyarylate. [7] The energy ray-curable composition for three-dimensional object formation according to any one of [1] to [6], wherein the polymerizable monomer (a) includes a polyfunctional polymerizable monomer. [8] The energy ray-curable composition for three-dimensional modeling according to any one of [1] to [7], wherein the absolute value of the difference between the refractive index n' of the energy ray-curable composition for three-dimensional modeling excluding the polymer compound (c) and the refractive index n of the polymer compound (c) is 0.3 or less. [9] An energy beam-curable three-dimensional object, in which, when the temperature dependence of dynamic viscoelasticity is measured, tan δ is multimodal with at least two peaks, and at least one tan δ peak position is 90°C or higher.

[10] The energy ray-curable three-dimensional object according to [9], wherein at least one tan δ peak position is 40° C. or lower.

[11] The energy ray-curable three-dimensional object according to [9] or

[10] , wherein the difference between the minimum temperature at the tan δ peak position and the maximum temperature at the tan δ peak position is 50° C. or more.

[12] A method for producing a dental material, using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8].

[13] A method for producing an orthodontic mouthpiece, using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8].

[14] A method for producing a mouthpiece for treating sleep disorders, using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8].

[15] A method for producing a mouthpiece for treating temporomandibular joint disease, using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8].

[16] A method for producing a mouthpiece for protecting teeth or temporomandibular joint, using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8].

[17] A method for producing a denture base material using the energy ray-curable composition for three-dimensional modeling according to any one of [1] to [8]. Effect of the Invention

[0012] According to the present invention, it is possible to provide an energy ray-curable composition for three-dimensional modeling, which has a hardening property that allows modeling by three-dimensional modeling and has excellent stress retention and toughness of a modeled object molded by three-dimensional modeling. The energy ray-curable composition for three-dimensional modeling of the present invention contains a polymerizable monomer (a), a photopolymerization initiator (b), and a polymerizable group-free polymer compound (c) having a glass transition temperature of 140°C or higher (hereinafter sometimes simply referred to as "polymer compound (c)"), and thereby a modeled object having excellent stress retention and toughness can be obtained. The cured product of the energy ray-curable composition for three-dimensional modeling of the present invention can also be suitably used as a mouthpiece for orthodontics, a mouthpiece for treating sleep disorders, a mouthpiece for treating temporomandibular joint disorders, and a mouthpiece for protecting teeth and temporomandibular joints. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] [Polymerizable monomer (a)] The polymerizable monomer (a) used in the energy ray curable three-dimensional modeling composition of the present invention is preferably a radical polymerizable monomer. Specific examples of the radical polymerizable monomer include (meth)acrylate polymerizable monomers; (meth)acrylamide polymerizable monomers; esters of α-cyanoacrylic acid, α-halogenated acrylic acid, crotonic acid, cinnamic acid, sorbic acid, maleic acid, itaconic acid, etc.; vinyl esters; vinyl ethers; mono-N-vinyl derivatives; styrene derivatives, etc. As the polymerizable monomer (a), from the viewpoint of curability, (meth)acrylate polymerizable monomers and (meth)acrylamide polymerizable monomers are preferred.

[0014] The polymerizable monomer (a) in the present invention is exemplified by a monofunctional polymerizable monomer having one polymerizable group and a polyfunctional polymerizable monomer having a plurality of polymerizable groups. From the viewpoint of excellent curability, it is preferable that the polyfunctional polymerizable monomer is contained. From the viewpoint of excellent flexibility and improving toughness of the cured product, it is preferable that the glass transition temperature is 40°C or less.

[0015] Examples of monofunctional (meth)acrylate polymerizable monomers include 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, 10-hydroxydecyl (meth)acrylate, propylene glycol mono(meth)acrylate, glycerol mono(meth)acrylate, erythritol mono(meth)acrylate, methyl (meth)acrylate, and ethyl (meth)acrylate. , propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, sec-butyl (meth)acrylate, t-butyl (meth)acrylate, isobutyl (meth)acrylate, n-hexyl (meth)acrylate, cyclohexyl (meth)acrylate, lauryl (meth)acrylate, cetyl (meth)acrylate, stearyl (meth)acrylate, isobornyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, benzyl (meth)acrylate, phenyl (meth)acrylate ester, o-phenylphenol (meth)acrylate, m-phenylphenol (meth)acrylate, p-phenylphenol (meth)acrylate, pentabromobenzyl (meth)acrylate, pentachlorophenyl (meth)acrylate, naphthyl (meth)acrylate, anthracenyl (meth)acrylate, anthracenemethyl (meth)acrylate, o-phenylphenoxymethyl (meth)acrylate, m-phenylphenoxymethyl (meth)acrylate, p-phenylphenoxymethyl (meth)acrylate, o-phenyl phenylphenoxyethyl (meth)acrylate, m-phenylphenoxyethyl (meth)acrylate, p-phenylphenoxyethyl (meth)acrylate, o-phenylphenoxypropyl (meth)acrylate, m-phenylphenoxypropyl (meth)acrylate, p-phenylphenoxypropyl (meth)acrylate, o-phenylphenoxybutyl (meth)acrylate, m-phenylphenoxybutyl (meth)acrylate, p-phenylphenoxybutyl (meth)acrylate, o-phenoxybenzyl (meth)acrylate,m-phenoxybenzyl (meth)acrylate, p-phenoxybenzyl (meth)acrylate, 2-(o-phenoxyphenyl)ethyl (meth)acrylate, 2-(m-phenoxyphenyl)ethyl (meth)acrylate, 2-(p-phenoxyphenyl)ethyl (meth)acrylate, 3-(o-phenoxyphenyl)propyl (meth)acrylate, 3-(m-phenoxyphenyl)propyl (meth)acrylate, 3-(p-phenoxyphenyl)propyl (meth)acrylate, 4-(o-phenoxyphenyl)butyl (meth)acrylate, 4-(m-phenoxyphenyl)butyl (meth)acrylate, 4-(p-phenoxyphenyl)butyl (meth)acrylate, 5-(o-phenoxyphenyl)pentyl (meth)acrylate, 5-(m-phenoxy (meth)acrylate, 5-(p-phenoxyphenyl)pentyl (meth)acrylate, 6-(o-phenoxyphenyl)hexyl (meth)acrylate, 6-(m-phenoxyphenyl)hexyl (meth)acrylate, 6-(p-phenoxyphenyl)hexyl (meth)acrylate, piperidinyl (meth)acrylate, tetramethylpiperidinyl (meth)acrylate, pentamethylpiperidinyl (meth)acrylate, (meth)acrylic acid, potassium (meth)acrylate, magnesium (meth)acrylate, zinc (meth)acrylate, 2,3-dibromopropyl (meth)acrylate, 3-(meth)acryloyloxypropyltrimethoxysilane, 11-(meth)acryloyloxyundecyltrimethoxysilane, and the like. Examples of monofunctional (meth)acrylamide polymerizable monomers include (meth)acrylamide, N-(meth)acryloylmorpholine, N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, N,N-di-n-propyl(meth)acrylamide, N,N-di-n-butyl(meth)acrylamide, N,N-di-n-hexyl(meth)acrylamide, N,N-di-n-octyl(meth)acrylamide, N,N-di-2-ethylhexyl(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, N,N-bis(2-hydroxyethyl)acrylamide, and N-(meth)acryloylcarbazole.Examples of the polymerizable monomer include N-methyl-N-phenyl(meth)acrylamide, N-(meth)acryloylmorpholine, N-piperidinyl acrylamide, N-tetramethylpiperidinyl acrylamide, N-2-methylpiperidinyl acrylamide, N-3-methylpiperidinyl acrylamide, and N-4-methylpiperidinyl acrylamide. These may be used alone or in combination of two or more. Among these, a polymerizable monomer that does not include an alicyclic skeleton is preferred in that the refractive index difference with the polymer compound (c) is unlikely to become large and the curing property is excellent. For example, benzyl (meth)acrylate, phenyl (meth)acrylate, o-phenylphenoxymethyl (meth)acrylate, m-phenylphenoxymethyl (meth)acrylate, p-phenylphenoxymethyl (meth)acrylate, o-phenylphenoxyethyl (meth)acrylate, m-phenylphenoxyethyl (meth)acrylate, p-phenylphenoxyethyl (meth)acrylate, o-phenylphenoxypropyl (meth)acrylate, m-phenylphenoxypropyl (meth)acrylate, p-phenylphenoxypropyl (meth)acrylate, o-phenylphenoxybutyl (meth)acrylate, Preferred are butyl (meth)acrylate, m-phenylphenoxybutyl (meth)acrylate, p-phenylphenoxybutyl (meth)acrylate, o-phenoxybenzyl (meth)acrylate, m-phenoxybenzyl (meth)acrylate, p-phenoxybenzyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, n-butyl (meth)acrylate, sec-butyl (meth)acrylate, t-butyl (meth)acrylate, isobutyl (meth)acrylate, N-(meth)acryloylmorpholine, N,N-dimethyl (meth)acrylamide, N,N-diethyl (meth)acrylamide, and the like. Furthermore, in terms of excellent flexibility and improving the toughness of the cured product, it is preferable that the glass transition temperature is 40° C. or lower, and for example, benzyl (meth)acrylate, phenyl (meth)acrylate, m-phenoxybenzyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, o-phenylphenoxyethyl (meth)acrylate, etc. are preferable.

[0016] The structure of the polyfunctional polymerizable monomer is not particularly limited, but a polyfunctional polymerizable monomer containing a urethane bond is preferred in terms of excellent curability. Also, an aromatic compound-based polyfunctional polymerizable monomer is preferred in terms of suppressing whitening of the cured product by making the refractive index difference with the polymer compound (c) less likely to become large.

[0017] The polyfunctional polymerizable monomer containing a urethane bond may be any compound in which a urethane bond is introduced adjacent to a (meth)acrylate group, and examples thereof include urethane-modified (meth)acrylate polymerizable monomers having at least one structure selected from the group consisting of polyester, polycarbonate, polyurethane, polyether, polyconjugated diene, and hydrogenated polyconjugated diene (hereinafter, these are also referred to as "polymer skeleton") in one molecule, and urethane-modified (meth)acrylate polymerizable monomers not having a polymer skeleton. Among these, urethane-modified (meth)acrylate polymerizable monomers having a polymer skeleton are preferred in terms of excellent flexibility, and those containing an aromatic ring in the repeating unit constituting the polymer skeleton are more preferred.

[0018] A urethane-modified (meth)acrylate-based polyfunctional polymerizable monomer having a polymer skeleton can be easily synthesized, for example, by addition reaction of a polyol containing the polymer skeleton, a compound having an isocyanate group (-NCO), and a (meth)acrylate compound having a hydroxyl group (-OH). A urethane-modified (meth)acrylate-based polyfunctional polymerizable monomer having a polymer skeleton can be easily synthesized by ring-opening addition reaction of a (meth)acrylate compound having a hydroxyl group with a lactone or an alkylene oxide, and then addition reaction of the resulting compound having a hydroxyl group at one end with a compound having an isocyanate group.

[0019] The polyol containing the polymer skeleton is not particularly limited as long as it has the above structure, and examples of the polyester include a polymer of phthalic acid and an alkylene diol having 2 to 12 carbon atoms, a polymer of adipic acid and an alkylene glycol having 2 to 12 carbon atoms, a polymer of maleic acid and an alkylene diol having 2 to 12 carbon atoms, a polymer of β-propiolactone, a polymer of γ-butyrolactone, a polymer of δ-valerolactone, a polymer of ε-caprolactone, and copolymers thereof. Examples of the polycarbonate include a polycarbonate derived from an aliphatic diol having 2 to 12 carbon atoms, a polycarbonate derived from bisphenol A, and a polycarbonate derived from an aliphatic diol having 2 to 12 carbon atoms and bisphenol A. Examples of the polyurethane include a polymer of an aliphatic diol having 2 to 12 carbon atoms and a diisocyanate having 1 to 12 carbon atoms. Examples of the polyether include polyethylene glycol, polypropylene glycol, polybutylene glycol, and poly(1-methylbutylene glycol). Polyconjugated dienes and hydrogenated polyconjugated dienes include 1,4-polybutadiene, 1,2-polybutadiene, polyisoprene, poly(butadiene-isoprene), poly(butadiene-styrene), poly(isoprene-styrene), polyfarnesene, and hydrogenated versions thereof.

[0020] Examples of compounds having an isocyanate group include hexamethylene diisocyanate (HDI), tolylene diisocyanate (TDI), xylylene diisocyanate (XDI), diphenylmethane diisocyanate (MDI), isophorone diisocyanate (IPDI), trimethylhexamethylene diisocyanate (TMHMDI), tricyclodecane diisocyanate (TCDDI), and adamantane diisocyanate (ADI).

[0021] Examples of the (meth)acrylate compound having a hydroxyl group include 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, 10-hydroxydecyl (meth)acrylate, 3-chloro-2-hydroxypropyl (meth)acrylate, 2-hydroxy-3-phenoxypropyl (meth)acrylate, glycerin mono(meth)acrylate, and N-hydroxyethyl (meth)acrylamide. , N,N-bis(2-hydroxyethyl)(meth)acrylamide, 2-hydroxy-3-acryloyloxypropyl(meth)acrylate, 2,2-bis[4-[3-(meth)acryloyloxy-2-hydroxypropoxy]phenyl]propane, 1,2-bis[3-(meth)acryloyloxy-2-hydroxypropoxy]ethane, pentaerythritol tri(meth)acrylate, and hydroxy(meth)acrylate compounds such as dipentaerythritol tri- or tetra(meth)acrylate.

[0022] The addition reaction between a compound having an isocyanate group and a (meth)acrylate compound having a hydroxyl group can be carried out according to a known method, and is not particularly limited.

[0023] Examples of the urethane-modified (meth)acrylate-based polyfunctional polymerizable monomer having a polymer skeleton obtained by the above method include reaction products of any combination of a polyol having at least one structure selected from the group consisting of polyester, polycarbonate, polyurethane, polyether, polyconjugated diene, and hydrogenated polyconjugated diene, a compound having an isocyanate group, and a (meth)acrylate compound having a hydroxyl group. As the urethane-modified (meth)acrylate-based polyfunctional polymerizable monomer having a polymer skeleton, commercially available products can also be used. Examples of commercially available products include urethane acrylates such as "UFC-01" (manufactured by Kyoeisha Chemical Co., Ltd.) and "EBECRYL8465" (manufactured by Daicel-Allnex Corporation). 。

[0024] The weight average molecular weight (Mw) of the urethane-modified (meth)acrylate-based polyfunctional polymerizable monomer having a polymer skeleton is, from the viewpoints of viscosity and strength, preferably from 500 to 50,000, more preferably from 750 to 30,000, and even more preferably from 1,000 to 15,000. Note that the weight average molecular weight (Mw) in the present invention means the weight average molecular weight in terms of polystyrene determined by gel permeation chromatography (GPC).

[0025] Examples of urethane-modified (meth)acrylate-based polyfunctional polymerizable monomers not having a polymer skeleton include 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (commonly known as "UDMA"), N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetra(meth)acrylate, phenyl glycidyl ether acrylate hexamethylene diisocyanate urethane prepolymer, pentaerythritol triacrylate hexamethylene diisocyanate urethane prepolymer, pentaerythritol triacrylate toluene diisocyanate urethane prepolymer, pentaerythritol triacrylate isophorone diisocyanate urethane prepolymer, and dipentaerythritol pentaacrylate hexamethylene diisocyanate urethane prepolymer.

[0026] Examples of aromatic compound-based polyfunctional polymerizable monomers include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-acryloyloxy)-2-hydroxypropoxyphenyl]propane, 2,2-bis[4-(3-methacryloyloxy)-2-hydroxypropoxyphenyl]propane (commonly known as "Bis-GMA"), 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytetraethoxyphenyl)propane, and 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane. acryloyloxydipropoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxyethoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxytriethoxyphenyl)propane, 2-(4-(meth)acryloyloxydipropoxyphenyl)-2-(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypropoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxyisopropoxyphenyl)propane, 1,4-bis(2-(meth)acryloyloxyethyl)pyromellitate, and the like. These may be used alone or in combination of two or more.

[0027] Examples of the aliphatic compound-based polyfunctional polymerizable monomer include bifunctional polymerizable monomers such as glycerol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, pentaethylene glycol di(meth)acrylate, hexaethylene glycol di(meth)acrylate, heptaethylene glycol di(meth)acrylate, octaethylene glycol di(meth)acrylate, nonaethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, tetrapropylene glycol di(meth)acrylate, pentapropylene glycol di(meth)acrylate, (meth)acrylate, hexapropylene glycol di(meth)acrylate, heptapropylene glycol di(meth)acrylate, octapropylene glycol di(meth)acrylate, nonapropylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 2-ethyl-1,6-hexanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, tricyclodecane dimethanol di(meth)acrylate, and the like.Examples of trifunctional or higher polymerizable monomers include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, 1,7-diacryloyloxy-2,2,6,6-tetra(meth)acryloyloxymethyl-4-oxaheptane, etc. These may be used alone or in combination of two or more.

[0028] When the polymerizable monomer (a) contains at least one of a urethane-type (meth)acrylate-based polyfunctional polymerizable monomer, an aliphatic compound-based polyfunctional (meth)acrylate-based polymerizable monomer, and an aromatic compound-based polyfunctional (meth)acrylate-based polymerizable monomer, the content of the polyfunctional (meth)acrylate-based polymerizable monomer in a total amount of 100 parts by mass of the polymerizable monomer (a) is preferably 20 to 90 parts by mass, more preferably 30 to 80 parts by mass, and even more preferably 40 to 70 parts by mass. When the polymerizable monomer (a) contains a monofunctional (meth)acrylate polymerizable monomer or a monofunctional (meth)acrylamide polymerizable monomer, the content of the monofunctional (meth)acrylate polymerizable monomer in the total amount of 100 parts by mass of the polymerizable monomer (a) is preferably 0 to 60 parts by mass, more preferably 5 to 55 parts by mass, and even more preferably 10 to 50 parts by mass. In this specification, the content of a certain polymerizable monomer in the total amount of 100 parts by mass of the polymerizable monomer components means the content (mass%) of the polymerizable monomer when the total amount of the polymerizable monomer components is converted to 100 mass%. Therefore, the total amount of each polymerizable monomer component does not exceed 100 parts by mass.

[0029] The content of the polymerizable monomer (a) in the energy ray-curable three-dimensional modeling composition of the present invention is not particularly limited as long as the effects of the present invention are exhibited, but from the viewpoint of the modeling property of the obtained energy ray-curable three-dimensional modeling composition and the toughness of the cured product, etc., the content is preferably 20 to 95 parts by mass, more preferably 40 to 90 parts by mass, in a total amount of 100 parts by mass of the energy ray-curable three-dimensional modeling composition of the present invention. By being 20 parts by mass or more, the viscosity of the energy ray-curable three-dimensional modeling composition is reduced, and a composition with excellent modeling properties can be obtained, and by being 95 parts by mass or less, a cured product of the energy ray-curable three-dimensional modeling composition having excellent toughness can be obtained.

[0030] [Photopolymerization initiator (b)] The photopolymerization initiator (b) can be selected from polymerization initiators generally used in industry, so long as it can produce the effects of the present invention. Among these, a radical photopolymerization initiator (b1) is preferably used.

[0031] Examples of the radical photopolymerization initiator (b1) include ketals, α-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, α-aminoketone compounds, (bis)acylphosphine oxides, oxime ester compounds, acridine compounds, and metallocene compounds. Examples of initiators for cationic polymerization include sulfonium salts, iodonium salts, phenacylsulfonium salts, hydroxyphenylsulfonium salts, sulfoxonium salts, sulfonic acid derivatives, phosphoric acid esters, phenolsulfonic acid esters, carboxylic acid esters, aryldiazonium salts, iron arene complexes, pyridinium salts, quinolinium salts, o-nitrobenzyl group-containing compounds, diazonaphthoquinones, and N-hydroxyimide sulfonates. These may be used alone or in combination of two or more.

[0032] Among these photopolymerization initiators (b), it is preferable to use at least one selected from the group consisting of (bis)acylphosphine oxides and their salts, oxime ester compounds, and acridine compounds, particularly when the wavelength of the light source used for three-dimensional modeling is 405 nm. Among these, (bis)acylphosphine oxides and their salts are particularly preferable.

[0033] Among the above (bis)acylphosphine oxides, examples of the acylphosphine oxides include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, 2,6-dichlorobenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, 2,4,6-trimethylbenzoylethoxyphenylphosphine oxide, 2,3,5,6-tetramethylbenzoyldiphenylphosphine oxide, benzoyldi(2,6-dimethylphenyl)phosphonate, 2,4,6-trimethylbenzoylphenylphosphine oxide sodium salt, 2,4,6-trimethylbenzoyldiphenylphosphine oxide potassium salt, and 2,4,6-trimethylbenzoyldiphenylphosphine oxide ammonium salt. Examples of bisacylphosphine oxides include bis(2,6-dichlorobenzoyl)phenylphosphine oxide, bis(2,6-dichlorobenzoyl)-2,5-dimethylphenylphosphine oxide, bis(2,6-dichlorobenzoyl)-4-propylphenylphosphine oxide, bis(2,6-dichlorobenzoyl)-1-naphthylphosphine oxide, bis(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2,5-dimethylphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, bis(2,5,6-trimethylbenzoyl)-2,4,4-trimethylpentylphosphine oxide, etc. Furthermore, compounds described in JP-A-2000-159621 can be mentioned. These may be used alone or in combination of two or more.

[0034] Among these (bis)acylphosphine oxides, it is preferable to use 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, and 2,4,6-trimethylbenzoylphenylphosphine oxide sodium salt, and it is particularly preferable to use 2,4,6-trimethylbenzoyldiphenylphosphine oxide and bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide from the viewpoint of excellent curability.

[0035] Examples of the oxime ester compounds include 1-[4-(phenylthio)phenyl]octane-1,2-dione=2-(O-benzoyloxime), 1-[6-(2-methylbenzoyl)-9-ethyl-9H-carbazol-3-yl]ethanone O-acetyloxime, and 2-(acetyloxyiminomethyl)thioxanthen-9-one. Commercially available products include "Irgacure OXE01", "Irgacure OXE02" (manufactured by BASF), and "N-1919" (manufactured by ADEKA Corporation). These may be used alone or in combination of two or more. The oxime ester compounds may have a heterocyclic structure in the molecule. By having a heterocyclic structure, the compounds have excellent absorption of light with a wavelength of about 385 nm or about 405 nm, and can improve sensitivity. Among the heterocyclic structures, in particular, the compound may have at least one selected from the group consisting of a carbazole skeleton, a xanthene skeleton, and a thioxanthone skeleton, and may be a compound having a carbazole skeleton.

[0036] The acridine-based compound is, for example, a compound represented by the following general formula [I]: [ka] (In the formula, R 1represents a halogen atom, an amino group, a carboxy group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, or an alkylamino group having 1 to 6 carbon atoms. m represents an integer of 0 to 5. a compound having one acridinyl group represented by the following general formula [II] [ka] (In the formula, R 2 represents an alkylene group having 2 to 20 carbon atoms, an oxadialkylene group having 2 to 20 carbon atoms, or a thiodialkylene group having 2 to 20 carbon atoms. Examples of the compound include a compound having two acridinyl groups represented by the following formula:

[0037] Examples of the acridine compound represented by general formula [I] include 9-phenylacridine, 9-(p-methylphenyl)acridine, 9-(m-methylphenyl)acridine, 9-(p-chlorophenyl)acridine, 9-(m-chlorophenyl)acridine, 9-aminoacridine, 9-dimethylaminoacridine, 9-diethylaminoacridine and 9-pentylaminoacridine. Examples of the acridine compounds represented by the general formula [II] include 1,2-bis(9-acridinyl)ethane, 1,3-bis(9-acridinyl)propane, 1,4-bis(9-acridinyl)butane, 1,5-bis(9-acridinyl)pentane, 1,6-bis(9-acridinyl)hexane, 1,7-bis(9-acridinyl)heptane, 1,8-bis(9-acridinyl)octane, 1,9-bis(9-acridinyl)nonane, 1,10-bis(9-acridinyl)decane, 1,1 ...hexane, 1,12-bis(9-acridinyl)hexane, 1,13-bis(9-acridinyl)hexane, 1,14-bis(9-acridinyl)hexane, 1,15-bis(9-acridinyl)hexane, 1,16-bis(9-acridinyl)hexane, 1,17-bis(9-acridinyl)heptane, 1,18-bis(9-acridinyl)octane, 1,19-bis(9-acridinyl)hexane, 1,20-bis(9-acridinyl)hexane, 1,2 Bis(9-acridinyl)alkanes such as 1,12-bis(9-acridinyl)undecane, 1,12-bis(9-acridinyl)dodecane, 1,14-bis(9-acridinyl)tetradecane, 1,16-bis(9-acridinyl)hexadecane, 1,18-bis(9-acridinyl)octadecane, and 1,20-bis(9-acridinyl)eicosane, 1,3-bis(9-acridinyl)-2-oxapropane, 1,3-bis(9-acridinyl)-2-thiapropane, and 1,5-bis(9-acridinyl)-3-thiapentane, etc. These may be used alone or in combination of two or more.

[0038] The content of the photopolymerization initiator (b) in the energy ray curable composition for three-dimensional modeling of the present invention is not particularly limited as long as the effects of the present invention are exhibited, but from the viewpoint of the curability of the obtained energy ray curable composition for three-dimensional modeling, it is preferably 0.01 to 1 part by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (a). If the content of the photopolymerization initiator (b) is less than 0.01 part by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (a), curing may not proceed sufficiently, and a molded product may not be obtained. The content of the photopolymerization initiator (b) is more preferably 0.05 parts by mass or more, and even more preferably 0.1 parts by mass or more, relative to 100 parts by mass of the total amount of the polymerizable monomer (a). On the other hand, if the content of the photopolymerization initiator (b) exceeds 10 parts by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (a), when the solubility of the photopolymerization initiator itself is low, it may cause precipitation from the energy ray-curable three-dimensional modeling composition, or the cured product may turn yellow due to increased absorption in the visible light region. The content of the photopolymerization initiator (b) is more preferably 7.5 parts by mass or less, and even more preferably 5 parts by mass or less, relative to 100 parts by mass of the total amount of the polymerizable monomer (a).

[0039] [High molecular compound (c)] As described above, it is important that the polymer compound (c) used in the energy ray-curable composition for three-dimensional modeling of the present invention does not have a polymerizable group and has a glass transition temperature of 140° C. or higher.

[0040] In the present invention, not having a polymerizable group means not having a radically polymerizable functional group, specifically, not having a (meth)acrylate group; a (meth)acrylamide group; an ester group obtained by esterifying α-cyanoacrylic acid, α-halogenated acrylic acid, crotonic acid, cinnamic acid, sorbic acid, maleic acid, itaconic acid, etc.; or a vinyl group. If the polymer compound (c) has a polymerizable group, it will polymerize with the polymerizable monomer (a), making it difficult to form a phase separation structure as described below, and the effects of the present invention cannot be obtained. Although a functional group such as an allyl group or a thiol group, which is inferior in activity to the above-mentioned functional group, may be included, it is more preferable that it does not include it.

[0041] In three-dimensional modeling, a model is produced by stacking layers on top of each other. Therefore, in order to obtain a model faithful to the design, the previous layer must be able to maintain a sufficiently stable shape at the time of stacking a new layer. That is, in the stereolithography method, in order to instantly harden the three-dimensional modeling composition during modeling, the initiator concentration in the three-dimensional modeling composition is increased as described above, and strong energy rays are irradiated to cause instant polymerization. However, when polymerization is allowed to proceed under such conditions, the resulting polymer chains are very short, and the physical entanglement of molecular chains and the chemical interaction force between molecular chains are difficult to work, so that stress retention is difficult to be exhibited. Stress retention can also be compensated for by adding a crosslinking agent, but since the number of crosslinks introduced into one molecule is small due to the shortness of the polymer chain, a small amount of the agent cannot improve the stress retention, and adding a large amount to obtain stress retention impairs flexibility and toughness. Here, the mechanism by which the energy ray-curable three-dimensional modeling composition containing the polymer compound (c) exhibits the effects of the present invention is unclear, but the present inventors presume it as follows. When a polymer compound (c) that does not have a polymerizable group is mixed in a state of being dissolved in a polymerizable component, the polymer compound (c) becomes insoluble with the polymerization of the polymerizable component of the energy ray-curable three-dimensional modeling composition during stereolithography, and a phase-separated structure consisting of a phase of the polymerizable component and a phase of the non-polymerizable component (phase of the polymer compound (c)) is formed in the model. When multiple polymers are mixed, the phase-separated structure that usually occurs is one in which the major component is a highly continuous phase. However, in the case of a phase-separated structure formed by using polymerization as a trigger as described above, the non-polymerizable component often becomes a highly continuous phase regardless of the amount of the polymerizable component and the non-polymerizable component. In other words, regardless of the content of the polymer compound (c), the phase of the polymer compound (c) can be made to be a highly continuous phase in the cured product. In this case, if the glass transition temperature of the polymer compound (c) is 140°C or higher, the effect of improving shape stability during modeling can be obtained. Furthermore, since the stress retention is predominantly affected by the highly continuous phase, high stress retention can be obtained when the glass transition temperature of the polymer compound (c) is 140°C or higher. On the other hand, since the hardened flexible phase of the polymerizable monomer (a) is scattered as a discontinuous phase, toughness can be maintained.In this way, by blending a polymer compound (c) having a glass transition temperature of 140°C or higher and no polymerizable group, shape stability during modeling can be improved and stress retention can be improved without impairing flexibility or toughness. The glass transition temperature of the polymer compound (c) is preferably 150°C or higher, more preferably 160°C or higher, and even more preferably 170°C or higher. The polymer compound (c) may be used alone or in combination of two or more types. However, when two or more types are mixed, the surface area of ​​the interface where the refractive index difference occurs becomes large and the cured product is likely to whiten, so it is preferable to use one type alone. When the absolute value of the difference between the refractive index n of the polymer compound (c) and the refractive index n' of the energy ray-curable three-dimensional modeling composition excluding the polymer compound (c) is 0.3 or less, whitening of the cured product due to the refractive index difference and the associated decrease in modeling properties are unlikely to occur. The absolute value of the refractive index difference is preferably 0.2 or less, more preferably 0.1 or less. In the present invention, the method for measuring the glass transition temperature of the polymer compound (c) is as described in the Examples below, and the peak position of tan δ determined by the measurement method described in the Examples below is referred to as the "glass transition temperature".

[0042] Among these polymer compounds (c), polycarbonate, polysulfone, polyethersulfone, and polyarylate are preferred, and polycarbonate, polysulfone, and polyarylate are particularly preferred because they are easily soluble in the polymerizable monomer (a), making it easy to increase the blending amount, and because they are highly effective in improving stress retention.

[0043] The content of the polymer compound (c) in the energy ray-curable three-dimensional modeling composition of the present invention is not particularly limited as long as the effects of the present invention are exhibited, but from the viewpoints of the modeling property of the obtained energy ray-curable three-dimensional modeling composition and the toughness of the cured product, the content is preferably 1.0 to 40 parts by mass, more preferably 5 to 30 parts by mass, in a total amount of 100 parts by mass of the energy ray-curable three-dimensional modeling composition of the present invention. By being 1.0 part by mass or more, a cured product of the energy ray-curable three-dimensional modeling composition having excellent toughness can be obtained, and by being 40 parts by mass or less, an increase in the viscosity of the energy ray-curable three-dimensional modeling composition is suppressed, and excellent modeling property can be obtained.

[0044] Specific examples of polycarbonates that can be used as the polymer compound (c) include "Novarex 7020R" manufactured by Mitsubishi Engineering Plastics Corporation, "Iupilon FPC-0220" manufactured by Mitsubishi Gas Chemical Company, Inc., and "Apec 1603", "Apec 1695", "Apec 1697", "Apec 1745", "Apec 1795", and "Apec 1897" manufactured by Covestro. Specific examples of polysulfones include "Udel PSU P-1700 NT" manufactured by Solvay Specialty Polymers, and "Ultrason S 2010" manufactured by BASF Ltd. Specific examples of polyethersulfones include "Veradel PESU 201 NT" manufactured by Solvay Specialty Polymers, and "Ultrason E 2020P" and "Ultrason E 7020P" manufactured by BASF Ltd. Specific examples of polyarylates include "U Polymer U-100" manufactured by Unitika Ltd.

[0045] [Phenol compounds (d)] From the viewpoint of discoloration suppression effect, the energy ray curable three-dimensional modeling composition of the present invention preferably further contains a phenolic compound (d). The phenolic compound (d) can be selected from phenol derivatives used in general industry, such as hydroquinone, hydroquinone monomethyl ether, dibutyl hydroquinone, dibutyl hydroquinone monomethyl ether, t-butyl catechol 2-t-butyl-4,6-dimethylphenol, 2,6-di-t-butylphenol, and 3,5-di-t-butyl-4-hydroxytoluene. Among these, 3,5-di-t-butyl-4-hydroxytoluene is preferred.

[0046] The content of the phenol-based compound (d) in the energy ray-curable composition for three-dimensional modeling of the present invention is not particularly limited, but is preferably 0.001 to 2.0 parts by mass, and more preferably 0.01 to 2.0 parts by mass, per 100 parts by mass of the total amount of the polymerizable monomers (c).

[0047] The energy ray-curable composition for three-dimensional modeling of the present invention is not particularly limited as long as it contains the above-mentioned polymerizable monomer (a), photopolymerization initiator (b), and polymer compound (c), and may contain, for example, other components other than the above. The content of other components in the energy ray-curable composition for three-dimensional modeling may be less than 50% by mass, less than 20% by mass, less than 10% by mass, or less than 1% by mass.

[0048] The energy ray-curable composition for three-dimensional modeling of the present invention may further contain a sensitizer, a chain transfer agent, an oxygen quencher, and the like to be used in combination with the initiator, as long as the effects of the present invention are not impaired.

[0049] The energy ray-curable composition for three-dimensional modeling of the present invention may further contain a known stabilizer for the purpose of suppressing deterioration or adjusting photocurability. Examples of such stabilizers include polymerization inhibitors and antioxidants.

[0050] The energy ray-curable composition for three-dimensional modeling of the present invention may further contain known additives for adjusting the mechanical properties and viscosity of the composition. Examples of such additives include inorganic particles, organic particles, organic solvents, and thickeners.

[0051] As described above, the energy ray curable three-dimensional modeling composition of the present invention forms a phase separation structure consisting of a polymerizable component phase and a non-polymerizable component phase (a polymer compound (c) phase having a glass transition temperature of 140° C. or higher and no polymerizable group) during photo-modeling. At this time, two tan δ peaks derived from the polymerizable component phase and the non-polymerizable component phase are detected. The position of this tan δ peak is basically not far from the glass transition temperature of the copolymer of the polymerizable component and the glass transition temperature of the non-polymerizable component (i.e., the glass transition temperature of the polymer compound (c)). However, when the compatibility of the polymerizable component and the non-polymerizable component is good, the two components are mixed in a small amount to form a phase, so that the tan δ peak position derived from the non-polymerizable component phase may be lower than the tan δ peak position of the polymer compound (c), i.e., the glass transition temperature. As a result of intensive research, the present inventors have found that high stress retention can be obtained when at least one tan δ peak position is 90° C. or higher. From the viewpoint of improving the stress retention, the tan δ peak position is preferably 100°C or higher, more preferably 110°C or higher, and even more preferably 120°C or higher. In addition, in order to increase the toughness, it is more effective for the phase of the polymerizable component dispersed in the cured product to be flexible. As a result of intensive research, the present inventors have found that the toughness is not impaired if at least one tan δ peak position is 40°C or lower. The tan δ peak position is preferably 30°C or lower, more preferably 20°C or lower, and even more preferably 10°C or lower. From the viewpoint of combining stress retention and toughness, the maximum tan δ peak position and the minimum tan δ peak position are preferably 50°C or higher apart, more preferably 70°C or higher apart, and even more preferably 90°C or higher apart.

[0052] In addition, since stereolithography freezes the phase structure instantaneously, when the compatibility between the polymerizable component and the non-polymerizable component is good, or when the viscosity of both components is high and the freezing of the phase structure occurs faster than the phase separation, the polymerizable component and the non-polymerizable component may be incompletely phase-separated, and an intermediate phase in which both are mixed may be formed. In this case, the tan δ peak is the phase of the polymerizable component, the intermediate phase, and the phase of the non-polymerizable component. There may be one type of intermediate phase or multiple types, but since it may reduce the continuity of the non-polymerizable component and inhibit the improvement of the stress retention, it is preferable that there is one type, and it is more preferable that no intermediate phase is formed. Therefore, an energy beam-curable three-dimensional object in which tan δ when the temperature dependence of dynamic viscoelasticity is measured is multimodal with at least two peaks, and at least one tan δ peak position is 90°C or higher can improve the stress retention. The method for measuring the loss tangent tan δ of the dynamic viscoelasticity of the energy beam-curable three-dimensional object is as described in the examples described later. In a preferred embodiment of the present invention, there is an energy ray-curable three-dimensional object in which tan δ is multimodal with at least two peaks when the temperature dependence of dynamic viscoelasticity is measured, and at least one tan δ peak position is 90° C. or higher. In the energy ray-curable three-dimensional object, in terms of excellent toughness, it is preferable that at least one tan δ peak position is 40° C. or lower. In addition, in the energy ray-curable three-dimensional object, in terms of excellent stress retention, the difference between the minimum temperature at the tan δ peak position and the maximum temperature at the tan δ peak position is preferably 70° C. or higher, more preferably 80° C. or higher, and even more preferably 90° C. or higher.

[0053] As described above, an embodiment (X-1) of the present invention includes an energy ray-curable composition for three-dimensional modeling, which contains a polymerizable monomer (a), a photopolymerization initiator (b), and a polymer compound (c), and the polymer compound (c) does not have a polymerizable group and has a glass transition temperature of 140° C. or higher. Another embodiment (X-2) includes an energy ray-curable composition for three-dimensional modeling, in the embodiment (X-1), in which the polymerization initiator (b) is a radical photopolymerization initiator (b1). Another embodiment (X-3) includes an energy ray-curable composition for three-dimensional modeling, in the embodiment (X-1) or (X-2), in which the polymerizable monomer (a) is a polymerizable monomer not having an alicyclic skeleton. Another embodiment (X-4) includes an energy ray-curable composition for three-dimensional modeling, in any of the embodiments (X-1) to (X-3), in which the glass transition temperature of the polymerizable monomer (a) is 40° C. or lower. Another embodiment (X-5) is the energy ray-curable composition for three-dimensional modeling in any one of the above-mentioned embodiments (X-1) to (X-4), wherein the polymer compound (c) has a glass transition temperature of 160° C. or higher. Another embodiment (X-6) is the energy ray-curable composition for three-dimensional modeling in any one of the above-mentioned embodiments (X-1) to (X-5), wherein the polymer compound (c) is at least one selected from polycarbonate, polysulfone, polyethersulfone, and polyarylate. Another embodiment (X-7) is the energy ray-curable composition for three-dimensional modeling in any one of the above-mentioned embodiments (X-1) to (X-6), wherein the polymerizable monomer (a) includes a polyfunctional polymerizable monomer. Another embodiment (X-8) is an energy ray-curable three-dimensional modeling composition according to any one of the above embodiments (X-1) to (X-7), in which the absolute value of the difference in refractive index between the refractive index n' of the energy ray-curable three-dimensional modeling composition excluding the polymer compound (c) and the refractive index n of the polymer compound (c) is 0.3 or less.Another embodiment (X-9) is an energy ray-curable three-dimensional modeled object in which, when the temperature dependence of dynamic viscoelasticity is measured, tan δ is multimodal with at least two peaks, and at least one tan δ peak position is 90° C. or higher.Another embodiment (X-10) is an energy ray-curable three-dimensional object in which at least one tan δ peak position is 40° C. or less in the embodiment (X-9). Another embodiment (X-11) is an energy ray-curable three-dimensional object in which the difference between the minimum temperature at the tan δ peak position and the maximum temperature at the tan δ peak position is 50° C. or more in the embodiment (X-9) or (X-10). Another embodiment (X-12) is a method for producing a dental material using the energy ray-curable three-dimensional modeling composition according to any one of the embodiments (X-1) to (X-8). Another embodiment (X-13) is a method for producing an orthodontic mouthpiece using the energy ray-curable three-dimensional modeling composition according to any one of the embodiments (X-1) to (X-8). Another embodiment (X-14) is a method for producing a mouthpiece for treating sleep disorders using the energy ray-curable three-dimensional modeling composition according to any one of the embodiments (X-1) to (X-8). Another embodiment (X-15) includes a method for producing a mouthpiece for treating temporomandibular joint disease using the energy ray-curable composition for three-dimensional modeling described in any one of the above embodiments (X-1) to (X-8). Another embodiment (X-16) includes a method for producing a mouthpiece for protecting teeth or the temporomandibular joint using the energy ray-curable composition for three-dimensional modeling described in any one of the above embodiments (X-1) to (X-8). Another embodiment (X-17) includes a method for producing a denture base material using the energy ray-curable composition for three-dimensional modeling described in any one of the above embodiments (X-1) to (X-8).

[0054] The energy ray curable composition for three-dimensional modeling preferably contains 0.01 to 10 parts by mass of the photopolymerization initiator (b), 0.5 to 40 parts by mass of the polymer compound (c), and 0.001 to 2.0 parts by mass of the phenol-based compound (d) relative to 100 parts by mass of the total amount of the polymerizable monomer (a). In addition, the energy ray curable composition for three-dimensional modeling more preferably contains 0.1 to 5 parts by mass of the polymerization initiator (b), 1 to 30 parts by mass of the polymer compound (c), and 0.01 to 2.0 parts by mass of the phenol-based compound (d). In any of the above-mentioned embodiments (X-1) to (X-16), the amount of each component can be appropriately changed based on the above explanation, and any component can be added, deleted, or otherwise modified. In any of the above-mentioned embodiments (X-1) to (X-16), the composition of each composition and the values ​​of each characteristic (modeling accuracy, yellowness, yellowing degree, etc.) can also be appropriately changed and combined.

[0055] The method for producing the energy ray-curable composition for three-dimensional modeling of the present invention is not particularly limited, and the composition can be produced according to a known method.

[0056] The energy ray-curable composition for three-dimensional modeling of the present invention is excellent in stress retention and toughness when molded by three-dimensional modeling. Therefore, the energy ray-curable composition for three-dimensional modeling of the present invention can be applied to applications that utilize such advantages, such as the manufacture of shaped objects by three-dimensional modeling; the manufacture of dental materials; the manufacture of various molded products such as film-like objects or molded objects by casting or casting; and molds for coating and vacuum molding, etc. In particular, the cured product of the energy ray-curable composition for three-dimensional modeling of the present invention can be suitably used as a mouthpiece for orthodontics, a mouthpiece for treating sleep disorders, a mouthpiece for treating temporomandibular joint disorders, and a mouthpiece for protecting teeth and temporomandibular joints.

[0057] When performing three-dimensional modeling using the energy ray curable three-dimensional modeling composition of the present invention, any of the conventionally known three-dimensional modeling methods and devices can be used. Among them, in the present invention, it is preferable to use active energy rays as light energy for curing a resin. "Active energy rays" means energy rays that can cure a photocurable resin composition, such as ultraviolet rays, electron beams, X-rays, radiation, high frequency waves, etc. For example, the active energy rays may be ultraviolet rays having a wavelength of 300 to 400 nm. Examples of light sources for active energy rays include lasers such as Ar lasers and He-Cd lasers; and lighting such as halogen lamps, xenon lamps, metal halide lamps, LEDs, mercury lamps, and fluorescent lamps, and lasers are particularly preferred. When a laser is used as a light source, it is possible to increase the energy level and shorten the modeling time, and furthermore, by utilizing the good focusing properties of the laser beam, a model with high modeling accuracy can be obtained.

[0058] As described above, when performing three-dimensional modeling using the energy ray-curable three-dimensional modeling composition of the present invention, any of the conventionally known methods and conventionally known optical modeling system devices can be adopted and are not particularly limited, but a representative example of a three-dimensional modeling method preferably used in the present invention is a method of finally obtaining a desired model by repeating a lamination step of selectively irradiating the energy ray-curable three-dimensional modeling composition with active energy rays to form a cured layer having a desired pattern, and then supplying an uncured liquid energy ray-curable three-dimensional modeling composition to the cured layer and irradiating it with active energy rays in the same manner to form a new cured layer continuous with the cured layer. The model obtained by this method may be used as it is, or may be used after further performing post-cure by light irradiation or post-cure by heat, etc., in some cases to further improve its mechanical properties or shape stability.

[0059] The structure, shape, size, etc. of the object obtained by the three-dimensional modeling method are not particularly limited and can be determined according to each application. Representative application fields of the three-dimensional modeling method of the present invention include models for verifying the appearance design during the design process; models for checking the functionality of parts; resin molds for producing casting molds; base models for producing metal molds; and direct molds for prototype metal molds. More specifically, the method includes the production of models for precision parts, electric and electronic parts, furniture, architectural structures, automobile parts, various containers, castings, metal molds, mother molds, etc., or models for processing, etc., and can be used extremely effectively for applications such as splints (aligners and retainers) for orthodontic purposes and dental splints including splints for treating sleep apnea syndrome, etc., by taking advantage of the characteristics of the color tone of the cured product and good modeling accuracy.

[0060] The present invention includes embodiments in which the above configurations are combined in various ways within the scope of the technical concept of the present invention, as long as the effects of the present invention are achieved. EXAMPLES

[0061] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to these examples, and many modifications within the scope of the technical concept of the present invention are possible by those skilled in the art. Each component used in the energy ray-curable three-dimensional modeling composition according to the examples or comparative examples will be described below together with its abbreviation.

[0062] [Polymerizable monomer (a)] POB-A: m-phenoxybenzyl acrylate (Kyoeisha Chemical Co., Ltd.) THF-A: Tetrahydrofurfuryl acrylate (Tokyo Chemical Industry Co., Ltd.) ACMO: N-acryloylmorpholine (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) D-2.6E: 2,2-bis[4-(meth)acryloyloxypolyethoxyphenyl]propane (manufactured by Shin-Nakamura Chemical Co., Ltd.) TCDDMA: Tricyclodecane dimethanol diacrylate (manufactured by Shin-Nakamura Chemical Co., Ltd.) EBECRYL8465: Urethane acrylate (manufactured by Daicel-Allnex Co., Ltd.) UFC-01: Urethane acrylate (Kyoeisha Chemical Co., Ltd.)

[0063] [Photopolymerization initiator (b)] TPO: 2,4,6-trimethylbenzoyldiphenylphosphine oxide (radical photopolymerization initiator, manufactured by IGMResins) Omnirad784: Bis(η5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium (radical photopolymerization initiator, manufactured by IGMResins) UVI-6970 (cationic photopolymerization initiator, triarylsulfonium salt, Union Carbide)

[0064] [High molecular compound (c)] Novarex 7020R (polycarbonate resin, manufactured by Mitsubishi Engineering Plastics Corporation) Glass transition temperature: 150°C Apec 1745 (polycarbonate resin, manufactured by Covestro) Glass transition temperature: 175°C Udel PSU P-1700 NT (polysulfone resin, Solvay Specialty Polymers) Glass transition temperature: 180°C U Polymer U-100 (polyarylate resin, manufactured by Unitika Ltd.) Glass transition temperature: 190°C

[0065] [Polymer compounds other than polymer compound (c)] Vylon 200 (polyester resin, manufactured by Toyobo Co., Ltd.) Glass transition temperature: 67°C Iupizeta FPC-0330 (polycarbonate resin, manufactured by Mitsubishi Gas Chemical Co., Ltd.) Glass transition temperature: 120°C

[0066] For the above-mentioned polymer compound (c), the peak temperature of tan δ of the cured product of the polymer compound (c) was measured as the glass transition temperature of the polymer compound (c) in the same manner as in the measurement of viscoelasticity (peak position of tan δ) described later.

[0067] [Phenol compounds (d)] BHT: 3,5-di-t-butyl-4-hydroxytoluene

[0068] (Examples 1 to 6 and Comparative Examples 1 to 3) The components shown in Table 1 were mixed at room temperature (20°C ± 15°C, JIS (Japanese Industrial Standards) Z 8703:1983) to prepare energy ray-curable compositions for three-dimensional modeling according to Examples 1 to 6 and Comparative Examples 1 to 3.

[0069] <Formability> Using the energy ray-curable three-dimensional modeling composition according to each Example and Comparative Example, a three-dimensional modeling device (DigitalWax (registered trademark) 028J+ manufactured by DWS, laser light source wavelength: 405 nm) was used to model test pieces with a thickness of 3.3 mm, width of 10.0 mm, and length of 64 mm (n=5). When a sheet with the exact dimensions could be modeled, it was marked as "○" (modelable), and when a three-dimensional object could not be obtained even once, it was marked as "×" (not modelable). The modeled test pieces were used to perform the evaluation described below.

[0070] <Stress retention> Using the energy ray curable three-dimensional modeling composition of each Example and Comparative Example, a sheet-like cured product having a length of 60 mm, a width of 20 mm, and a thickness of 1.0 mm was produced using the same device as above, and the obtained model was washed with ethanol to remove unpolymerized polymerizable monomers, and then polymerized by a light irradiator (Otoflash (registered trademark) G171 manufactured by EnvisionTEC Co., Ltd.), and punched out with a dumbbell-shaped No. 8 punching blade according to JIS K 6251:2010 (vulcanized rubber and thermoplastic rubber - Determination of tensile properties) to produce tensile test pieces (n = 5). The obtained test pieces were used to evaluate the stress retention (stress retention rate). Specifically, using a universal testing machine (manufactured by Shimadzu Corporation, EZ Test EZ-SX 500N), the test pieces were pulled 0.5 mm at a crosshead speed of 20 mm / min with a jig distance of 10 mm, and then held for 24 hours with a gripper distance of 0.5 mm, and the stress decay behavior was observed. The stress retention rate τ (%) was calculated from the measurement results using the following formulas (1) and (2): Formula (1) represents the stress σ (t) after t hours have elapsed since deformation was applied. σ(t)=Fe(t) / W (1) (In the formula, Fe represents the load after t hours have elapsed under a strain of 0.5 mm, and W represents the width of the parallel part of the test piece.) τ = σ(24) / σ(0) × 100 (2) In this test, the stress retention rate τ (%) is preferably 20% or more, and more preferably 30% or more.

[0071] <Toughness> Using the energy ray-curable three-dimensional modeling compositions of each Example and Comparative Example, acrylic resins for denture bases (length 39.0 mm, width 4.0 mm, thickness (height) 8.0 mm, notch depth 3.0 mm, angle 45°) described in JIS T 6501:2012 were produced using the same equipment as above. The resulting model was washed with ethanol to remove unpolymerized polymerizable monomers, and then polymerized using a light irradiator (Otoflash (registered trademark) G171 manufactured by EnvisionTEC) to obtain a cured product. The resulting cured product was stored at room temperature in the air for one day, and then a bending strength test was performed to evaluate the toughness. That is, a fracture toughness test was performed by bending test using a universal testing machine (Shimadzu Corporation, Autograph AG-I 100kN) with a support distance of 32 mm and a crosshead speed of 1 mm / min (n=5). The toughness was 1.0 kJ / mm 2 It is preferable that the concentration is 2.0 kJ / mm or more. 2 More preferably, it is 3.0 kJ / mm 2 More preferably, it is equal to or greater than this.

[0072] <Measurement of viscoelasticity (peak position of tan δ)> Using the energy ray curable three-dimensional modeling composition of each Example and Comparative Example, a cured product having a diameter of 25 mm and a thickness of 1.0 mm was prepared using a light irradiation machine (Otofolash (registered trademark) G171 manufactured by envisionTEC Co., Ltd.), and the viscoelasticity of the cured product was measured in the range of -50 ° C to 200 ° C using a rheometer (Rheogel-E4000 manufactured by UBM Co., Ltd.), and the peak position of tan δ was measured. If tan δ is bimodal or more, it is suggested that a phase separation structure is formed in the cured product. Furthermore, if the peak position of tan δ is 90 ° C or more, the stress retention is likely to be high, and it is more preferable that it is 110 ° C or more, and even more preferable that it is 130 ° C or more.

[0073] [Table 1]

[0074] As shown in Table 1, the energy ray-curable 3D modeling compositions of Examples 1 to 6 had a curability that allowed modeling, and the cured products were excellent in stress retention and toughness. In addition, the tan δ of these cured products was bimodal, suggesting that the cured products had a phase-separated structure. In addition, at least one peak position of tan δ was 90°C or higher. The energy ray-curable 3D modeling composition of Comparative Example 1 caused significant stress relaxation in its cured product, and the stress retention and toughness were insufficient. For the energy ray-curable 3D modeling compositions of Comparative Examples 2 and 3, the tan δ of the cured products was bimodal, suggesting that they had a phase-separated structure. As a result, although the toughness was excellent, the peak position of tan δ was less than 90°C due to the low glass transition temperature of the polymer compound (c) contained therein, and the stress retention was insufficient.

Claims

1. The composition comprises a polymerizable monomer (a), a photopolymerization initiator (b), and a polymer compound (c), the polymer compound (c) having no polymerizable group and a glass transition temperature of 140° C. or higher, The polymerizable monomer (a) is (i) a (meth)acrylate-based polymerizable monomer, or (ii) a (meth)acrylate-based polymerizable monomer and a (meth)acrylamide-based polymerizable monomer, An energy ray-curable composition for three-dimensional modeling, in which, when the temperature dependence of dynamic viscoelasticity is measured, tan δ is multimodal with at least two peaks, and at least one tan δ peak position is 90° C. or higher.

2. The energy ray-curable composition for three-dimensional object formation according to claim 1 , wherein the photopolymerization initiator (b) is a radical photopolymerization initiator (b1).

3. The energy ray-curable composition for three-dimensional modeling according to claim 1 or 2, wherein the polymerizable monomer (a) is a polymerizable monomer having no alicyclic skeleton.

4. 4. The energy ray-curable composition for three-dimensional modeling according to claim 1, wherein the polymerizable monomer (a) has a glass transition temperature of 40° C. or lower.

5. The energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 4, wherein the polymer compound (c) has a glass transition temperature of 160°C or higher.

6. The energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 5, wherein the polymer compound (c) is at least one selected from the group consisting of polycarbonate, polysulfone, polyethersulfone, and polyarylate.

7. The energy ray-curable composition for three-dimensional object formation according to any one of claims 1 to 6, wherein the polymerizable monomer (a) includes a polyfunctional polymerizable monomer.

8. 8. The energy ray-curable composition for three-dimensional modeling according to claim 1, wherein an absolute value of a difference between a refractive index n' of the energy ray-curable composition for three-dimensional modeling excluding the polymer compound (c) and a refractive index n of the polymer compound (c) is 0.3 or less.

9. The energy ray-curable three-dimensional object according to any one of claims 1 to 8, wherein at least one tan δ peak position is 40°C or lower.

10. The energy ray-curable three-dimensional object according to any one of claims 1 to 9, wherein a difference between a minimum temperature at a tan δ peak position and a maximum temperature at a tan δ peak position is 50°C or more.

11. A method for producing a dental material, using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

12. A method for producing an orthodontic mouthpiece, using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

13. A method for producing a mouthpiece for treating sleep disorders, using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

14. A method for producing a mouthpiece for treating temporomandibular joint disorders, using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

15. A method for producing a mouthpiece for protecting teeth or temporomandibular joints, using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

16. A method for producing a denture base material by using the energy ray-curable composition for three-dimensional modeling according to any one of claims 1 to 10.

Citation Information

Patent Citations

  • Model material ink, ink set and method for manufacturing 3D molded object

    JP2016112824A

  • Material set for stereo molding, manufacturing method of stereo molded article, manufacturing method of dental prosthetic, and manufacturing apparatus for stereo molded article

    JP2017081153A

  • Composition for optical three-dimensional molding and method for manufacturing three-dimensionally molded article using the same

    JP2018100340A

  • Ink composition for molding object manufacturing, manufacturing method of ink composition for molding object manufacturing, molding object and molding object manufacturing apparatus

    JP2019051679A

  • Printable compositions containing high viscosity components and methods for producing 3D articles therefrom

    JP2019519405A